Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture

Launched by EN CHU KONG HOSPITAL · Jul 7, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new type of ureteral stent, which is a small tube placed in the ureter (the tube that connects the kidney to the bladder) to help treat patients with a condition called ureteral stricture. This condition causes the ureter to narrow, leading to problems like kidney swelling and pain. The trial aims to see how well this self-expanding stent works over a longer period of time and to ensure it is safe for people who have not found relief from previous treatments.

To be eligible for the trial, participants should be between the ages of 18 and 80 and have had a ureteral stricture that did not improve after at least two attempts to widen it. However, individuals with serious heart issues, those who are not willing to have the stent placed for a longer time, or those with uncontrolled urinary infections cannot participate. If you join the study, you can expect regular check-ups to monitor how well the stent is working and to ensure your safety throughout the process. This trial is currently recruiting participants and aims to help improve treatment options for people experiencing these challenging kidney issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • refractory ureteral stricture after at least two times of ureteral dilation
• Exclusion Criteria:
• • poor cardiovascular function for anesthesia unwilling to accept the long-term placement of ureteral stent uncontrolled urinary tract infection